Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Mark Palmer from Coker Palmer issued a price target of $475.00 for DAVE on 2026-07-01 12:43:37.The adjusted price target was set to $475.00.At the time of the announcement,
July 1, 2026 DAVE 7.82%
from Raymond James issued a price target of $50.00 for FUNC on 2026-07-01 10:12:40.The adjusted price target was set to $50.00.At the time of the announcement, FUNC...
July 1, 2026 FUNC 1.70%
from Robert W. Baird issued a price target of $15.00 for TSHA on 2026-06-30 11:08:49.The adjusted price target was set to $15.00.At the time of the announcement,
June 30, 2026 TSHA -2.86%
Christopher Chen from Robert W. Baird issued a price target of $5.00 for LRMR on 2026-06-30 11:06:55.The adjusted price target was set to $5.00.At the time of the announcement,...
June 30, 2026 LRMR 3.44%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SCLXW Scilex Holding Company | 0.17
34.85% | ||||||||||||||||||
| SJ Scienjoy Holding Corporat | 0.97
24.36% | ||||||||||||||||||
| SKIL Skillsoft Corp. | 6.42
23.94% | ||||||||||||||||||
| ELTX Elicio Therapeutics, Inc. | 4.80
22.76% | ||||||||||||||||||
| LGO Largo Inc. | 0.77
22.11% | ||||||||||||||||||
| DAVEW Dave Inc. | 2.90
20.33% | ||||||||||||||||||
| SY So-Young International In | 1.74
17.57% | ||||||||||||||||||
| LICN Lichen International Limi | 1.16
16.99% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -4.45%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -0.26%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.21%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.78%